Advertisement

Marijuana Use and Related Health Care Encounters in Colorado Before and After Retail Legalization

  • Daniel I. Vigil
  • Mike Van Dyke
  • Katelyn E. Hall
  • Alexandra Elyse Contreras
  • Tista S. Ghosh
  • Larry Wolk
Original Article

Abstract

With legalization of retail marijuana in Colorado, and the opening of dispensaries in January 2014, two key questions were how legalization would impact marijuana use and whether there would be an increase in adverse health events. Legalization did not noticeably impact marijuana use rates among adolescents or young adults. Past-30-day use among adolescents remained steady for more than ten years, pre- and post-legalization. Use among 18–25-year-olds has gradually increased for over ten years, with no change in the trend around legalization. However, healthcare encounters with mention of marijuana have increased after legalization. Poison center calls among 9–17-year-olds have markedly increased, while calls for 18–25-year-olds saw a modest increase. Meanwhile, the portion of hospitalizations with a marijuana code increased modestly among 9–17-year-olds but tripled among 18–25-year-olds, reaching 8.1% in 2014–2015. Healthcare encounters with mention of marijuana are rare among 0–8-year-olds, but have increased. Several future efforts are important. These include: 1) detailed analysis of use patterns, especially among individuals who use marijuana frequently 2) further research and improved data on healthcare encounters with mention of marijuana, to clarify their nature, cause, and severity and 3) research on long-term health effects of marijuana use with particular focus on the effects of greater frequency and quantity of use.

Keywords

Marijuana Cannabis Legalization Prevalence Healthcare Hospitalization 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. Center for Behavioral Health Statistics and Quality. (2016). Key substance use and mental health indicators in the United States: results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16-4984, NSDUH Series H-51). Retrieved from http://www.samhsa.gov/data/
  2. Centers for Medicare & Medicaid Services (2017) ICD-10—Centers for Medicare & Medicaid Services. Retrieved from https://www.cms.gov/Medicare/Coding/ICD10/
  3. Gunn, J. K. L., Rosales, C. B., Center, K. E., Nuñez, A., Gibson, S. J., Christ, C., & Ehiri, J. E. (2016). Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open, 6(4), e009986.  https://doi.org/10.1136/bmjopen-2015-009986.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Levine, A., Clemenza, K., Rynn, M., & Lieberman, J. (2017). Evidence for the risks and consequences or adolescent cannabis exsposure. Journal of the American Academy of Child and Adolescent Psychiatry, 56(3), 214–225.  https://doi.org/10.1016/j.jaac.2016.12.014.CrossRefPubMedGoogle Scholar
  5. National Academies of Sciences, Engineering, and medicine. (2017). The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington, DC: The National Academies Press.  https://doi.org/10.17226/24625.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Daniel I. Vigil
    • 1
  • Mike Van Dyke
    • 1
  • Katelyn E. Hall
    • 1
  • Alexandra Elyse Contreras
    • 1
  • Tista S. Ghosh
    • 1
  • Larry Wolk
    • 1
  1. 1.Colorado Department of Public Health and EnvironmentDenverUSA

Personalised recommendations